Alpha-1 Foundation

 

Despite its small diagnosed patient population, Alpha-1 Foundation has invested more than $76 million in research and programs as it vows to find a cure for Alpha-1 antitrypsin deficiency, a condition that can result in serious lung and liver disease. Foundation leaders like to say they fight outside their weight class and credit Blackbaud healthcare solutions for their outsized impact.

Find more stories like this: